Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation

Endocrinology

Volumn 141, Issue 5, 2000, Pages 1667-1674

  Deckers, Martine M L ^a,c   Karperien, Marcel ^a   Van Der Bent, Chris ^a   Yamashita, Takeyoshi ^b   Papapoulos, Socrates E ^a   Löwik, Clemens W G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KIRIN BREWERY CO LTD   (Japan)

^c Building 1 C4R 89 ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; NEUROPILIN; PARATHYROID HORMONE; SOMATOMEDIN C; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; ENDOTHELIUM CELL; MINERALIZATION; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034457236     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.5.7458     Document Type: Article

References (56)

1. Role of osteoblasts in hormonal control of osteoblast resorption: A hypothesis
2. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone
3. Regulation of fracture repair by growth factors
4. Endothelial cells in culture secrete a potent bone cell active mitogen
5. Autocrine activities of basic FGF: Regulation of cell movement, plasminogen activator synthesis and DNA synthesis
6. Promotion of calvarial cell osteogenesis by endothelial cells
7. Endothelin-1 is a potent regulator of human bone cell metabolism in vitro
8. Angiogenesis
9. Characterization, regulation, and function of specific cell membrane receptors for insulin-like growth factor I on bone endothelial cells
10. 3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells
11. VEGF couples hypertrophic cartilage remodeling, ossifiaction and angiogenesis during endochondral bone formation
12. Vascular permeability factor and endothelial cell mitogen related to PDGF
13. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
14. Isolation and characterisation of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
15. The biology of VEGF
16. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
17. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
18. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
19. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
20. VEGF-related molecules in tumours
21. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
22. Suppression of pulmonary metastasis by angiogenesis inhibtor TNP1470 in murine osteosarcoma
23. Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor/vascular endothelial growth factor family
24. Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature
25. Isolation of human placental cDNA coding for a protein related to the vascular permeability factor
26. Vascular endothelial growth factor (VEGF) and its receptors
27. Identification of a new endothelial growth receptor tyrosine kinase
28. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor
29. VEGF-C receptor binding and pattern of expression with VEGFR3 suggests a role in lymphatic vascular development
30. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FLT4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
31. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain
32. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
33. Neuropilin-1 is a placenta growth factor-2 receptor
34. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts
35. 3 induces the expression of vascular endothelial growth factor in osteoblastic cells
36. 3 in human osteoblast-like cells
37. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I
38. Expression and regulation of vascular endothelial growth factor in osteoblasts
39. Subcloning of three osteoblastic cell lines with distict differentiation phenotypes from the mouse osteoblastic cell line KS-4
40. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells
41. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
42. IL-1α, IL-1β, IL-6 and TNT-α steady state mRNA levels analyzed by RT-competitive-PCR in bone marrow of gonadectomized mice
43. Role of the FLT-1 receptor tyrosine kinase in regulating the assembly of vascular endothetium
44. Structure of a wildtype and mutant mouse β2-microglobulin genes
45. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathway
46. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family
47. Molecular cloning of murine Flt and Flt4
48. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of growth plate chondrocytes
49. Molecular mechanisms mediating proliferation and differentiation interrelationships during progressive development of the osteoblast phenotype
50. Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts
51. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells
52. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis
53. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
54. The 230 kDa form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ, pathway and partially induces mitotic signals in NIH3T3 fibroblasts
55. Overexpression of a membrane protein, neuropilin, in chimeri mice causes anomalies in the cardiovascular system, nervous system and limbs
56. VEGF can substitute for MCSF in the support of osteoclastic bone resorption